The field of genetic and cellular medicines is advancing at an unprecedented pace, and there is no better place to witness this evolution than the ASGCT 2026 Annual Meeting. Taking place from May 11–15, 2026, at the Thomas M. Menino Convention & Exhibition Center in Boston, MA, this event serves as the premier global gathering for gene and cell therapy (CGT) professionals.
This year’s program features nine curated tracks designed to cover the entire CGT ecosystem. Attendees will explore breakthroughs in viral and non-viral delivery platforms, CRISPR-based gene editing, and the integration of artificial intelligence in drug discovery. As the industry matures, a significant focus remains on navigating the complex regulatory frameworks established by the FDA’s Center for Biologics Evaluation and Research (CBER) and the EMA’s Committee for Advanced Therapies (CAT).
Key highlights for 2026 include symposia on process intensification for economical manufacturing and tools for human iPSC-derived models. With thousands of researchers, clinicians, and regulatory experts in attendance, the meeting offers unparalleled opportunities for networking and collaborative breakthroughs that will define the next generation of patient care.
Strategic planning for these advanced therapies requires a deep understanding of evolving ICH Quality Guidelines and manufacturing scalability. Whether you are presenting an abstract or evaluating new technologies in the exhibit hall, the insights gained in Boston will be critical for any organization looking to lead in the biotechnology sector.
To ensure your innovative therapy successfully navigates the path from clinical development to commercialization, partner with the pharma consulting experts at DES Pharma.
Frequently Asked Questions (FAQ) About ASGCT (In Boston for 2026)
- When and where is the ASGCT 2026 Annual Meeting?
- The event will be held May 11–15, 2026, at the Thomas M. Menino Convention & Exhibition Center in Boston, Massachusetts.
- Who should attend this event?
- The meeting is designed for academic researchers, clinicians, bio-industry professionals, regulatory agency representatives, equipment manufacturers, and patient advocates involved in gene and cell therapy.
- What are the primary tracks for the 2026 program?
- The meeting features nine tracks, including:
-
Viral and Non-viral Delivery Platforms
-
Gene Editing Technologies
-
Cell and Immune Therapies
-
Clinical Translation and Regulatory Strategy
-
AI and Digital Transformation in CGT
-
- The meeting features nine tracks, including:
- Are there virtual attendance options?
- Yes, the ASGCT 2026 Annual Meeting is a hybrid event. Registration options are available for both in-person attendance in Boston and virtual access to sessions.
- What is the registration cost?
- While rates vary by membership status, the non-member advanced registration fee for the hybrid event is approximately $1,500, with a virtual-only option available for approximately $700.
- Is Wi-Fi provided at the venue?
- Complimentary basic Wi-Fi will be provided to all registered attendees throughout the convention center and exhibit hall.
